AMA and LexisNexis Risk Solutions Join Resources for an Efficient Approach to Network Directory Management

ATLANTA and CHICAGO - Addressing the increasing expectation on health plans to present patients with accurate directories of available health care professionals, the American Medical Association (AMA) and LexisNexis® Risk Solutions today announced a collaboration to offer a solution that simplifies a successful strategy for constantly maintaining high-quality data for use in network directories.

The collaboration combines the industry-leading data resources of the AMA, its wholly owned subsidiary AMA Business Solutions, and LexisNexis Health Care to provide a holistic solution, LexisNexis VerifyHCP, to pre-fill, collect, monitor, cleanse, and update clinician data. The innovative solution to be available by the end of 2016 will create efficiencies for health insurers and clinicians that streamline the process of maintaining an accurate and up-to-date network directory.

Changes to clinician data naturally occur and erode the accuracy of network directories. Accurate directories are necessary for consumers to make informed decisions and enrollees to find suitable medical care. As federal and state agencies tighten regulations for providing patients with up-to-date and accurate lists of health care professionals, health plans face an evolving mix of rules and mandates. As a result, physician offices are burdened with an increase in repetitious data verification requests from health plans that are required to constantly ensure the quality of network directories.

“It has never been more important for both operational and compliance purposes to identify, validate and update clinician data in real-time,” said Josh Schoeller, Vice President, Client Engagement, LexisNexis Health Care. “Working in collaboration, the AMA and LexisNexis Health Care are offering a comprehensive and authoritative solution that delivers a flow of accurate data to meet state and federal directory mandates, and most importantly, supports the needs of patients, physicians and payers.”

“LexisNexis Health Care provides unique analytic technology and proven capabilities that complement the AMA’s extensive data resources and supports the important goal of providing patients with accurate network directories,” saidAMA Senior Vice President of Health Solutions Laurie McGraw. “Working together to solve a significant industry challenge will provide physicians a simplified alternative to updating practice information with multiple payers that reduces administrative burdens and workflow disruptions.”

The collaboration builds on each organization’s capabilities and complements a mutual commitment to provide a flexible solution for an evolving environment. For more information please visit LexisNexis VerifyHCP website.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.